• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Further studies on the hypercoagulable state of patients with Cushing's syndrome.

作者信息

Patrassi G M, Dal Bo Zanon R, Boscaro M, Martinelli S, Girolami A

出版信息

Thromb Haemost. 1985 Aug 30;54(2):518-20.

PMID:4082087
Abstract

Factors XII, XI, IX and VIII, plasminogen and alpha 2-antiplasmin levels were found to be increased in a group of patients affected by Cushing's syndrome. High activity of these coagulation factors could be due to their increased release and synthesis mediated by cortisol. A significant correlation between the main arterial pressure and either factor VIII antigen, ristocetin cofactor or factor XII activity was found. Moreover a similar correlation between factor XII activity and either factor VIII antigen or ristocetin cofactor was seen. In conclusion, the presence of a hypercoagulable state in Cushing's syndrome seems confirmed. Synergic release of factor XII and factor VIII from endothelium could be due to high blood vessel tone secondary to hypercorticism. Finally, decreased fibrinolytic activity was suspected according to plasminogen and alpha 2-antiplasmin increase.

摘要

相似文献

1
Further studies on the hypercoagulable state of patients with Cushing's syndrome.
Thromb Haemost. 1985 Aug 30;54(2):518-20.
2
Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state.
Thromb Haemost. 1982 Apr 30;47(2):116-7.
3
Clotting changes in Cushing's syndrome: elevated factor VIII activity.库欣综合征的凝血变化:凝血因子VIII活性升高。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(2):268-77.
4
Clotting changes in borderline hypertension.临界高血压的凝血变化
J Hum Hypertens. 1987 Sep;1(2):101-3.
5
The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
Blood Coagul Fibrinolysis. 1992 Dec;3(6):789-93. doi: 10.1097/00001721-199212000-00013.
6
Haemostatic abnormalities in canine Cushing's syndrome.犬库欣综合征的止血异常。
Res Vet Sci. 1986 Sep;41(2):228-30.
7
Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.库欣综合征中的高凝状态:特定止血和纤溶标志物的作用。
Endocrine. 2009 Aug;36(1):70-4. doi: 10.1007/s12020-009-9186-y. Epub 2009 Apr 21.
8
Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.肾病综合征患者的凝血因子Ⅻ及其他止血蛋白异常
Thromb Haemost. 1982 Aug 24;48(1):27-32.
9
[Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].[猫凝血因子VIII:C、IX、XI和XII活性的测定]
Zentralbl Veterinarmed A. 1995 Oct;42(8):513-20.
10
Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients.57例狼疮及狼疮样抗凝物的生物学和临床异质性
J Med. 1987;18(3-4):199-217.

引用本文的文献

1
The Cortisol Effect on the NO/cGMP Pathway.皮质醇对一氧化氮/环磷酸鸟苷途径的影响。
Int J Mol Sci. 2025 Feb 8;26(4):1421. doi: 10.3390/ijms26041421.
2
Daytime plasma cortisol and cortisol response to dexamethasone suppression are associated with a prothrombotic state in hypertension.白天血浆皮质醇和地塞米松抑制试验后的皮质醇反应与高血压患者的血栓前状态有关。
Front Endocrinol (Lausanne). 2024 May 21;15:1397062. doi: 10.3389/fendo.2024.1397062. eCollection 2024.
3
Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men-A Randomised Placebo-Controlled Trial.
健康男性每日一次服用50毫克泼尼松龙进行10天治疗对止血功能的影响——一项随机安慰剂对照试验
Biomedicines. 2023 Jul 21;11(7):2052. doi: 10.3390/biomedicines11072052.
4
Role of Prednisolone in Platelet Activation by Inhibiting TxA Generation through the Regulation of cPLA Phosphorylation.泼尼松龙通过调节cPLA磷酸化抑制血栓素A生成在血小板活化中的作用
Animals (Basel). 2023 Apr 11;13(8):1299. doi: 10.3390/ani13081299.
5
Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of disease.评估库欣综合征在疾病短期和长期缓解后促凝失衡的情况。
J Endocrinol Invest. 2022 Jan;45(1):9-16. doi: 10.1007/s40618-021-01605-5. Epub 2021 Jun 11.
6
Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery.肾上腺功能对手术患者止血/内皮功能的影响。
J Endocr Soc. 2021 Mar 23;5(5):bvab047. doi: 10.1210/jendso/bvab047. eCollection 2021 May 1.
7
Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.评估急性淋巴细胞白血病患儿发生症状性血栓栓塞的遗传性和获得性血栓前状态缺陷:一项前瞻性观察队列研究方案
BMC Cancer. 2017 May 4;17(1):313. doi: 10.1186/s12885-017-3306-5.
8
Coagulation Profile in Patients with Different Etiologies for Cushing Syndrome: A Prospective Observational Study.不同病因库欣综合征患者的凝血指标:一项前瞻性观察研究。
Horm Metab Res. 2017 May;49(5):365-371. doi: 10.1055/s-0043-100113. Epub 2017 Feb 22.
9
A venous thromboembolism risk assessment model for patients with Cushing's syndrome.一种用于库欣综合征患者的静脉血栓栓塞风险评估模型。
Endocrine. 2016 May;52(2):322-32. doi: 10.1007/s12020-015-0665-z. Epub 2015 Jun 26.
10
Approach to chemotherapy-associated thrombosis.化疗相关性血栓形成的处理方法
Vasc Med. 2015 Apr;20(2):153-61. doi: 10.1177/1358863X14568705.